Mark Nathan Lampert
Fondateur chez BVF, Inc.
Provenance du réseau au premier degré de Mark Nathan Lampert
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Mendel Biotechnology, Inc.
 Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Mendel Biotechnology, Inc. operates as a plant biotechnology company. It develops genetic and chemical solutions for a range of agricultural markets. The firm offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company was founded in 1997 and is headquartered in Newark, CA.
11
| Subsidiary | Miscellaneous Commercial Services | 11 |
BVF Partners LP
 BVF Partners LP Investment ManagersFinance BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts.
8
| Subsidiary | Investment Managers | 8 |
| Extinct | Medical Specialties | 6 | |
BVF, Inc.
 BVF, Inc. Investment Banks/BrokersFinance BVF, Inc. manages engages in investment business and manages biotech focused hedge funds. The firm manages Biotechnology Value Fund LP and Biotechnology Value Fund II LP. The company was founded by Mark Nathan Lampert on September 14, 1993 and is headquartered in San Francisco, CA.
3
| Private Company | Investment Banks/Brokers | 3 |
AvMax, Inc.
 AvMax, Inc. Pharmaceuticals: MajorHealth Technology AvMax, Inc. develops pharmaceutical products. It commercializes pharmaceutical formulations. The company was founded by Leslie Z. Benet in 1993 and is headquartered in San Francisco, CA.
2
| Private Company | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mark Nathan Lampert via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Undergraduate Degree | |
| MONSANTO | Wholesale Distributors | Corporate Officer/Principal Private Equity Investor | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Chairman | |
| AEROCRINE AB | Electronic Equipment/Instruments | Chief Executive Officer | |
| TRILLIUM THERAPEUTICS | Biotechnology | Chairman Director/Board Member | |
Ironshore Therapeutics, Inc.
 Ironshore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ironshore Therapeutics, Inc. operates as a pharmaceutical company. The firm offers HLD-200, HLD-900, the morning routine and the delexis products. It develops commercialization of a proprietary drug delivery system. The company was founded by David Gordon MacLeod Lickrish in 2008 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Chairman | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree | |
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cahill Gordon & Reindel LLP
 Cahill Gordon & Reindel LLP Miscellaneous Commercial ServicesCommercial Services Cahill Gordon & Reindel LLP provides legal services. Its practice areas include antitrust, bankruptcy and restructuring, corporate governance and investigations, crisis advisory and management, employee benefits, insurance, intellectual property, litigation, media, real estate, tax, and trusts. The company was founded by Joseph P. Cotton, George S. Franklin, William G. McAdoo and Francis McAdoo in 1919 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Latham & Watkins LLP
 Latham & Watkins LLP Miscellaneous Commercial ServicesCommercial Services Latham & Watkins LLP operates as a full-service law firm or legal matters. It offers services in the areas of finance, litigation, accounting, banking, life sciences, private equity, real estate, government relations, employment law, and outsourcing. The company was founded in 1934 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| OREXO AB | Pharmaceuticals: Major | Director/Board Member | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree | |
| The State University of New York | College/University | Undergraduate Degree | |
| THERMO FISHER SCIENTIFIC | Medical Specialties | Corporate Officer/Principal | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| SENSORION | Pharmaceuticals: Major | Chairman | |
| Sun Yat-Sen University | College/University | Undergraduate Degree | |
Aquilo Capital Management LLC
 Aquilo Capital Management LLC Investment ManagersFinance Aquilo Capital Management LLC (Aquilo) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. Aquilo was founded in 2010 to manage investment funds and separately managed accounts for individual clients. | Investment Managers | Director of Investments | |
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
EcoR1 Capital, LLC
 EcoR1 Capital, LLC Investment ManagersFinance EcoR1 Capital LLC (EcoR1) is an independent registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Oleg Nodelman in 2012. EcoR1 serves as the general partner of and investment adviser to investment funds and provides investment advice to separate account clients. | Investment Managers | Director of Research - Equity | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Chief Executive Officer | |
Sri Capital
 Sri Capital Investment ManagersFinance Sri Capital (Sri Capital) is venture capital firm founded in 2007. Sri Capital headquartered in the US. | Investment Managers | Private Equity Investor | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Chairman | |
Limelight Bio, Inc.
 Limelight Bio, Inc. BiotechnologyHealth Technology Limelight Bio, Inc. engages in the development of proprietary technologies, advanced targets, and drug candidates for the expansion of current gene therapy and gene editing approaches. The company was founded by Phil Johnson and Jean Bennett in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chief Operating Officer | |
| Clearview Projects, Inc. | Corporate Officer/Principal | ||
| MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Law School | College/University | Graduate Degree | |
| GH RESEARCH PLC | Pharmaceuticals: Major | Director/Board Member | |
GH Research Ireland Ltd.
 GH Research Ireland Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, GH Research Ireland Ltd. is an Irish clinical-stage biopharmaceutical company that develops innovative therapies for the treatment of mental illnesses. The company is based in Dublin, Ireland and is a subsidiary of GH Research Plc. | Miscellaneous Commercial Services | Director/Board Member | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Octagon Capital Advisor/ Private Equity
 Octagon Capital Advisor/ Private Equity Investment ManagersFinance Octagon Capital Advisor/ Private Equity (Octagon Capital) is a private equity subsidiary of Octagon Capital Advisors LP founded in 2019 by Ting Jia. The firm is headquartered in New York. | Investment Managers | Founder | |
| 4D MOLECULAR THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| Weill Cornell Graduate School of Medical Sciences | College/University | Doctorate Degree | |
Vedere Bio II, Inc.
 Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
AnHeart Therapeutics, Inc.
 AnHeart Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Nuvation Bio, Inc., AnHeart Therapeutics, Inc. is a clinical stage biopharmaceutical company based in New York, NY. AnHeart Therapeutics is focused on developing a pipeline of novel precision oncology therapeutics for areas of significant unmet medical need. The company's lead investigational therapy, taletrectinib, is a next-generation ROS1-inhibitor currently in pivotal phase 2 trials for ROS1-positive non-small cell lung cancer (NSCLC). AnHeart Therapeutics, Inc. also has a second investigational therapy, safusidenib, being evaluated in a phase 2 trial for -mutant glioma. AnHeart Therapeutics is supported by leading life sciences investors and has built an organization with deep oncology drug discovery and development expertise. The company was founded by Bing Yan, Junyuan Jerry Wang, Lihua Zheng, and the CEO is Junyuan Jerry Wang. AnHeart Therapeutics was acquired by Nuvation Bio, Inc. on April 09, 2024 for $89.30 million. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 36 |
| Suède | 3 |
| Canada | 3 |
| Suisse | 3 |
| Irlande | 3 |
Sectorielle
| Health Technology | 23 |
| Consumer Services | 12 |
| Finance | 7 |
| Commercial Services | 7 |
| Distribution Services | 2 |
Opérationnelle
| Director/Board Member | 63 |
| Corporate Officer/Principal | 43 |
| Independent Dir/Board Member | 21 |
| Undergraduate Degree | 18 |
| President | 15 |
Relations les plus connectées
| Insiders | |
|---|---|
| Scott Myers | 18 |
| Mitchell Kaye | 16 |
| Derek Rapp | 15 |
| Diana Hausman | 13 |
| Leslie Z. Benet | 11 |
| Matthew Perry | 10 |
| Robert L. Kirkman | 9 |
| TJ Jia | 9 |
| Gwen A. Fyfe | 9 |
| Spike Loy | 9 |
| David Shin | 9 |
| Kanishka Pothula | 8 |
| Steve Padgette | 7 |
| Gorjan Hrustanovic | 7 |
| Thor Nagel | 6 |
- Bourse
- Insiders
- Mark Nathan Lampert
- Connexions Sociétés
